Mohammed S. Taghour - Search Results

Year	Number of Results
2019	1
2020	2
2021	8
2022	10
2023	9
2024	3

1

Discovery of new VEGFR-2 inhibitors and apoptosis inducer-based thieno[2,3-d]pyrimidine.

El-Metwally SA, Elkady H, Hagras M, Elkaeed EB, Alsfouk BA, Doghish AS, Ibrahim IM, Taghour MS, Husein DZ, Metwaly AM, Eissa IH. El-Metwally SA, et al. Among authors: taghour ms. Future Med Chem. 2023 Nov;15(22):2065-2086. doi: 10.4155/fmc-2023-0130. Epub 2023 Nov 13. Future Med Chem. 2023. PMID: 37955128

2

New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulations.

Mahdy HA, Elkady H, Taghour MS, Elwan A, Dahab MA, Elkady MA, Elsakka EG, Elkaeed EB, Alsfouk BA, Ibrahim IM, Eissa IH, Metwaly AM. Mahdy HA, et al. Among authors: taghour ms. Future Med Chem. 2023 Jul;15(14):1233-1250. doi: 10.4155/fmc-2023-0089. Epub 2023 Jul 19. Future Med Chem. 2023. PMID: 37466069

3

Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative Evaluation.

Elwan A, Abdallah AE, Mahdy HA, Dahab MA, Taghour MS, Elkaeed EB, Mehany ABM, Nabeeh A, Adel M, Alsfouk AA, Elkady H, Eissa IH. Elwan A, et al. Among authors: taghour ms. Molecules. 2022 Aug 8;27(15):5047. doi: 10.3390/molecules27155047. Molecules. 2022. PMID: 35956997 Free PMC article.

4

Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms.

Eldehna WM, Taghour MS, Al-Warhi T, Nocentini A, Elbadawi MM, Mahdy HA, Abdelrahman MA, Alotaibi OJ, Aljaeed N, Elimam DM, Afarinkia K, Abdel-Aziz HA, Supuran CT. Eldehna WM, et al. Among authors: taghour ms. J Enzyme Inhib Med Chem. 2022 Dec;37(1):531-541. doi: 10.1080/14756366.2021.2024528. J Enzyme Inhib Med Chem. 2022. PMID: 34991416 Free PMC article.

5

Design, synthesis, and biological evaluation of novel bioactive thalidomide analogs as anticancer immunomodulatory agents.

Kotb AR, Bakhotmah DA, Abdallah AE, Elkady H, Taghour MS, Eissa IH, El-Zahabi MA. Kotb AR, et al. Among authors: taghour ms. RSC Adv. 2022 Nov 22;12(52):33525-33539. doi: 10.1039/d2ra06188k. eCollection 2022 Nov 22. RSC Adv. 2022. PMID: 36505721 Free PMC article.

6

Design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies of new thieno[2,3-d]pyrimidines targeting VEGFR-2.

El-Metwally SA, Elkady H, Hagras M, Husein DZ, Ibrahim IM, Taghour MS, El-Mahdy HA, Ismail A, Alsfouk BA, Elkaeed EB, Metwaly AM, Eissa IH. El-Metwally SA, et al. Among authors: taghour ms. RSC Adv. 2023 Aug 4;13(33):23365-23385. doi: 10.1039/d3ra03128d. eCollection 2023 Jul 26. RSC Adv. 2023. PMID: 37545598 Free PMC article.

7

Targeting VEGFR-2 by new quinoxaline derivatives: Design, synthesis, antiproliferative assay, apoptosis induction, and in silico studies.

Alsaif NA, Mahdy HA, Alanazi MM, Obaidullah AJ, Alkahtani HM, Al-Hossaini AM, Al-Mehizi AA, Elwan A, Taghour MS. Alsaif NA, et al. Among authors: taghour ms. Arch Pharm (Weinheim). 2022 Feb;355(2):e2100359. doi: 10.1002/ardp.202100359. Epub 2021 Dec 3. Arch Pharm (Weinheim). 2022. PMID: 34862634

8

Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2,4-diones targeting VEGFR-2 and apoptosis pathway.

Taghour MS, Elkady H, Eldehna WM, El-Deeb N, Kenawy AM, Elkaeed EB, Alsfouk BA, Alesawy MS, Husein DZ, Metwaly AM, Eissa IH. Taghour MS, et al. PLoS One. 2022 Sep 23;17(9):e0272362. doi: 10.1371/journal.pone.0272362. eCollection 2022. PLoS One. 2022. PMID: 36149902 Free PMC article.

9

Design, synthesis and molecular docking of new [1,2,4] triazolo[4,3-a]quinoxaline derivatives as anticancer agents targeting VEGFR-2 kinase.

Alsaif NA, Elwan A, Alanazi MM, Obaidullah AJ, Alanazi WA, Alasmari AF, Albassam H, Mahdy HA, Taghour MS. Alsaif NA, et al. Among authors: taghour ms. Mol Divers. 2022 Aug;26(4):1915-1932. doi: 10.1007/s11030-021-10303-6. Epub 2021 Aug 30. Mol Divers. 2022. PMID: 34460053

10

Discovery of new pyrimidine-5-carbonitrile derivatives as anticancer agents targeting EGFR^WT and EGFR^T790M.

Nasser AA, Eissa IH, Oun MR, El-Zahabi MA, Taghour MS, Belal A, Saleh AM, Mehany ABM, Luesch H, Mostafa AE, Afifi WM, Rocca JR, Mahdy HA. Nasser AA, et al. Among authors: taghour ms. Org Biomol Chem. 2020 Oct 7;18(38):7608-7634. doi: 10.1039/d0ob01557a. Org Biomol Chem. 2020. PMID: 32959865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year